Hansel D.E. Kane C.J. Paner G.P. et al.The kidney: a comprehensive guide to pathologic diagnosis and management. Springer, New York, NY

History of the development of the classification of renal cell neoplasia.

Clin Lab Med. 25: 231-246

The history of urologic pathology: an overview.

Histopathology. 74: 184-212Mancilla-Jimenez R. Stanley R.J. Blath R.A.

Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases.

Cancer. 38: 2469-2480

Mostofi FK, Sesterhenn IA, and Sobin LH. Histological typing of kidney tumours, 1981, World Health Organization; Geneva, Switzerland.

Thoenes W. Storkel S. Rumpelt H.J.

Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Pathol Res Pract. 181: 125-143Szucs S. Muller-Brechlin R. DeRiese W. et al.

Deletion 3p: the only chromosome loss in a primary renal cell carcinoma.

Cancer Genet Cytogenet. 26: 369-373Kovacs G. Wilkens L. Papp T. et al.

Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis.

J Natl Cancer Inst. 81: 527-530

Low chromosome number in chromophobe renal cell carcinomas.

Genes Chromosomes Cancer. 4: 267-268Storkel S. Eble J.N. Adlakha K. et al.

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

Cancer. 80: 987-989Kovacs G. Akhtar M. Beckwith B.J. et al.

The Heidelberg classification of renal cell tumours.

J Pathol. 183: 131-133Mostofi F.K. Davis C.J. Sobin L.H.

Histological typing of kidney tumors.

2nd edition. Springer; Geneva, Switzerland, Eble J.N. Sauter G. Epstein J.I. et al.

World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs.

IARC; Lyon, France, Moch H. Humphrey P.A. Ulbright T.M. et al.4th edition. WHO classification of tumours of the urinary system and male genital organs. 8. IARC, Lyon, FranceUrinary and male genital tumours (WHO classification of tumours). IARC, Lyon, FranceMoch H. Amin M.B. Berney D.M. et al.

The 2022 World Health Organization Classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours.

Eur Urol. 82: 458-468Ricketts C.J. Linehan W.M. Spellman P.T. et al.Cancer Genome Atlas Research Network

Comprehensive molecular characterization of papillary renal-cell carcinoma.

N Engl J Med. 374: 135-145Chan E. Stohr B.A. Butler R.S. et al.

Papillary renal cell carcinoma with microcystic architecture is strongly associated with extrarenal invasion and metastatic disease.

Am J Surg Pathol. 46: 392-403Palsgrove D.N. Li Y. Pratilas C.A. et al.

Eosinophilic Solid and Cystic (ESC) renal cell carcinomas harbor tsc mutations: molecular analysis supports an expanding clinicopathologic spectrum.

Am J Surg Pathol. 42: 1166-1181Falzarano S.M. McKenney J.K. Montironi R. et al.

Renal cell carcinoma occurring in patients with prior neuroblastoma: a heterogenous group of neoplasms.

Am J Surg Pathol. 40: 989-997Medeiros L.J. Palmedo G. Krigman H.R. et al.

Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity.

Am J Surg Pathol. 23: 772-780Trpkov K. Williamson S.R. Gill A.J. et al.

Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Mod Pathol. 34: 1167-1184Amin M.B. McKenney J.K. Martignoni G. et al.

Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis.

Mod Pathol. 35: 1306-1316Tao J.J. Wei G. Patel R. et al.

ALK fusions in renal cell carcinoma: response to entrectinib.

JCO Precis Oncol. 2: 1-8Shah R.B. Stohr B.A. Tu Z.J. et al.

"Renal cell carcinoma with leiomyomatous stroma" harbor somatic mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity.

Am J Surg Pathol. 44: 571-581Srinivasan R. Su D. Stamatakis L. et al.

5 Mechanism based targeted therapy for hereditary leiomyomatosis and renal cell cancer (HLRCC) and sporadic papillary renal cell carcinoma: interim results from a phase 2 study of bevacizumab and erlotinib.

Eur J Cancer. 50: 8Anglade F. Milner Jr., D.A. Brock J.E.

Can pathology diagnostic services for cancer be stratified and serve global health?.

Cancer. 126: 2431-2438

Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more.

J Urol. 79: 196-201Robson C.J. Churchill B.M. Anderson W.

The results of radical nephrectomy for renal cell carcinoma.

J Urol. 101: 297-301Bonsib S.M. Gibson D. Mhoon M. et al.

Renal sinus involvement in renal cell carcinomas.

Am J Surg Pathol. 24: 451-458

The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas.

Am J Surg Pathol. 28: 1594-1600

T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas.

J Urol. 174: 1199-1202

Renal veins and venous extension in clear cell renal cell carcinoma.

Mod Pathol. 20: 44-53Amin M.B. Edge S. Greene F. et al.

AJCC cancer staging manual.

8th edition. Springer International Publishing: American Joint Committee on Cancer; Chicago, IL, Paner G.P. Chumbalkar V. Montironi R. et al.

Updates in grading of renal cell carcinomas beyond clear cell renal cell carcinoma and papillary renal cell carcinoma.

Adv Anat Pathol. 29: 117-130Delahunt B. Eble J.N. Egevad L. et al.

Grading of renal cell carcinoma.

Histopathology. 74: 4-17Fuhrman S.A. Lasky L.C. Limas C.

Prognostic significance of morphologic parameters in renal cell carcinoma.

Am J Surg Pathol. 6: 655-663Moch H.H.P. Ulbright T.M. Reuter V.E.

WHO classification of tumours of the urinary system and male genital organs.

WHO Classification of Tumours. 4th edition. 8. IARC, Lyon, FranceOhashi R. Martignoni G. Hartmann A. et al.

Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme.

Virchows Arch. 476: 409-418Volpe A. Novara G. Antonelli A. et al.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

BJU Int. 110: 76-83Lopez-Beltran A. Montironi R. Cimadamore A. et al.

Grading of chromophobe renal cell carcinoma: do we need it?.

Eur Urol. 79: 232-233Avulova S. Cheville J.C. Lohse C.M. et al.

Grading chromophobe renal cell carcinoma: evidence for a four-tiered classification incorporating coagulative tumor necrosis.

Eur Urol. 79: 225-231Cheville J.C. Lohse C.M. Sukov W.R. et al.

Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.

Am J Surg Pathol. 36: 851-856Wilcox Vanden Berg R.N. Basourakos S.P. LaRussa S. et al.

Management of the small renal mass: a 2020 update.

Curr Oncol Rep. 22: 69

Histologic diagnosis of renal mass biopsy.

Arch Pathol Lab Med. 143: 705-710Campbell R.A. Scovell J. Rathi N. et al.

Partial versus radical nephrectomy: complexity of decision-making and utility of AUA guidelines.

Clin Genitourin Cancer. 20: 501-509Campbell S.C. Clark P.E. Chang S.S. et al.

Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I.

J Urol. 206: 199-208Campbell S.C. Uzzo R.G. Karam J.A. et al.

Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part II.

J Urol. 206: 209-218